Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis

  • Benjamin Goeppert
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  • Damian Stichel
    Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Reka Toth
    Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Sarah Fritzsche
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  • Moritz Anton Loeffler
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  • Anna Melissa Schlitter
    Institute of Pathology, Technische Universitat of Munich, Munich, Germany
  • Olaf Neumann
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  • Yassen Assenov
    Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Monika Nadja Vogel
    Diagnostic and Interventional Radiology, Thoraxklinik at University Hospital Heidelberg, Heidelberg, Germany
  • Arianeb Mehrabi
    Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
  • Katrin Hoffmann
    Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
  • Bruno Köhler
    Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
  • Christoph Springfeld
    Liver Cancer Center Heidelberg (LCCH), Heidelberg, Germany
  • Dieter Weichenhan
    Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Christoph Plass
    German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany
  • Irene Esposito
    Institute of Pathology, Heinrich-Heine-Universitat Dusseldorf, Dusseldorf, Germany
  • Peter Schirmacher
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
  • Andreas von Deimling
    Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • Stephanie Roessler
    Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

書誌事項

公開日
2021-01-19
権利情報
  • http://creativecommons.org/licenses/by-nc/4.0/
DOI
  • 10.1136/gutjnl-2020-322983
公開者
BMJ

この論文をさがす

説明

<jats:sec> <jats:title>Objective</jats:title> <jats:p>A detailed understanding of the molecular alterations in different forms of cholangiocarcinogenesis is crucial for a better understanding of cholangiocarcinoma (CCA) and may pave the way to early diagnosis and better treatment options.</jats:p> </jats:sec> <jats:sec> <jats:title>Design</jats:title> <jats:p>We analysed a clinicopathologically well-characterised patient cohort (n=54) with high-grade intraductal papillary (IPNB) or tubulopapillary (ITPN) neoplastic precursor lesions of the biliary tract and correlated the results with an independent non-IPNB/ITPN associated CCA cohort (n=294). The triplet sample set of non-neoplastic biliary epithelium, precursor and invasive CCA was analysed by next generation sequencing, DNA copy number and genome-wide methylation profiling.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p> Patients with invasive CCA arising from IPNB/ITPN had better prognosis than patients with CCA not associated with IPNB/ITPN. ITPN was localised mostly intrahepatic, whereas IPNB was mostly of extrahepatic origin. IPNB/ITPN were equally associated with small-duct and large-duct type intrahepatic CCA. IPNB exhibited mutational profiles of extrahepatic CCA, while ITPN had significantly fewer mutations. Most mutations were shared between precursor lesions and corresponding invasive CCA but <jats:italic>ROBO2</jats:italic> mutations occurred exclusively in invasive CCA and <jats:italic>CTNNB1</jats:italic> mutations were mainly present in precursor lesions. In addition, IPNB and ITPN differed in their DNA methylation profiles and analyses of latent methylation components suggested that IPNB and ITPN may have different cells-of-origin. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Integrative analysis revealed that IPNB and ITPN harbour distinct early genetic alterations, IPNB are enriched in mutations typical for extrahepatic CCA, whereas ITPN exhibited few genetic alterations and showed distinct epigenetic profiles. In conclusion, IPNB/ITPN may represent a distinctive, intermediate form of intrahepatic and extrahepatic cholangiocarcinogenesis.</jats:p> </jats:sec>

収録刊行物

  • Gut

    Gut 71 (2), 391-401, 2021-01-19

    BMJ

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ